Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission

Go back to Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
(NASDAQ: INBS) Delayed: 1.81 -0.14 (7.18%)
Previous Close $1.95    52 Week High
Open $1.95    52 Week Low
Day High $1.96    P/E N/A 
Day Low $1.79    EPS
Volume 48,388